MRNA:OTCQB-Marina Biotech Inc (USD)

COMMON STOCK | Biotechnology | OTCQB - U.S. Registered

Last Closing

USD 137

Change

+3.60 (+2.70)%

Market Cap

USD 0.02B

Volume

3.41M

Analyst Target

USD 89.73
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Marina Biotech Inc is a biotechnology company. The Company is engaged in the discovery, development and commercialization of nucleic acid-based therapies to treat orphan diseases.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-24 )

Largest Industry Peers for Biotechnology

Symbol Name Price(Change) Market Cap
VRTX Vertex Pharmaceuticals Inc

-1.49 (-0.31%)

USD 122.24B
REGN Regeneron Pharmaceuticals Inc

-18.30 (-1.71%)

USD 115.08B
ALNY Alnylam Pharmaceuticals Inc

+1.83 (+0.75%)

USD 28.20B
ARGX argenx NV ADR

-0.94 (-0.21%)

USD 26.78B
BNTX BioNTech SE

-2.14 (-2.59%)

USD 20.40B
BGNE BeiGene Ltd

-0.86 (-0.59%)

USD 17.50B
GMAB Genmab AS

-0.09 (-0.35%)

USD 16.65B
BMRN Biomarin Pharmaceutical Inc

-1.75 (-2.05%)

USD 15.98B
RPRX Royalty Pharma Plc

+0.09 (+0.34%)

USD 15.90B
UTHR United Therapeutics Corporatio..

-2.02 (-0.63%)

USD 13.71B

ETFs Containing MRNA

MRN3:LSE Leverage Shares 3x Long M.. 300.10 % 0.00 %

-1.98 (-0.69%)

USD 0.37M
CURE:XETRA VanEck Genomics and Healt.. 9.78 % 0.00 %

-0.21 (-0.69%)

USD 7.06M
XGEN:XETRA Xtrackers MSCI Genomic He.. 7.35 % 0.00 %

-0.16 (-0.69%)

USD 3.56M
XDNA:CA iShares Genomics Immunolo.. 6.81 % 0.00 %

-0.30 (-0.69%)

CAD 4.90M
CURG:LSE VanEck Genomics and Healt.. 6.47 % 0.00 %

-0.11 (-0.69%)

USD 7.06M
MSGR 6.26 % 0.00 %

N/A

N/A
BTEC:SW iShares Nasdaq US Biotech.. 5.32 % 0.00 %

-0.14 (-0.69%)

USD 0.52B
GN0M:XETRA Global X Genomics & Biote.. 5.14 % 0.00 %

-0.05 (-0.69%)

USD 7.05M
GNOM:SW Global X Genomics & Biote.. 5.14 % 0.00 %

-0.02 (-0.69%)

USD 6.95M
HVAX:CA 4.95 % 0.00 %

N/A

N/A
GNOG:LSE Global X Genomics & Biote.. 4.85 % 0.00 %

-0.03 (-0.69%)

USD 6.91M
XGES:LSE Xtrackers MSCI Genomic He.. 4.28 % 0.00 %

-0.13 (-0.69%)

USD 3.56M
XNNV:XETRA Xtrackers MSCI Innovation.. 3.91 % 0.00 %

-0.11 (-0.69%)

USD 8.02M
LSEQ Harbor Long-Short Equity .. 3.72 % 0.00 %

+0.13 (+-0.69%)

USD 0.01B
CDNA:CA CI Bio-Revolution ETF 3.71 % 0.00 %

N/A

CAD 5.70M
ARCG:LSE ARK Genomic Revolution UC.. 3.67 % 0.00 %

-5.63 (-0.69%)

USD 2.30M
XNNS:LSE Xtrackers MSCI Innovation.. 3.38 % 0.00 %

-0.05 (-0.69%)

USD 8.02M
XNNV:LSE Xtrackers MSCI Innovation.. 3.38 % 0.00 %

+0.03 (+-0.69%)

USD 8.02M
XMLH:F Legal & General Ucits Etf.. 2.65 % 0.00 %

N/A

USD 0.07B
DOCT:SW L&G Healthcare Breakthrou.. 2.65 % 0.00 %

N/A

USD 0.07B
RSPH Invesco S&P 500® Equal.. 2.26 % 0.00 %

-0.02 (-0.69%)

USD 1.02B
ZUH:CA BMO Equal Weight US Healt.. 1.65 % 0.39 %

-0.14 (-0.69%)

CAD 0.29B
CURE:AU ETFS S&P Biotech ETF 1.61 % 0.00 %

-0.87 (-0.69%)

USD 0.04B
TAEQ 1.46 % 0.00 %

N/A

N/A
XBI SPDR® S&P Biotech ETF 1.43 % 0.35 %

+0.67 (+-0.69%)

USD 6.65B
WEBA:XETRA Amundi US Tech 100 Equal .. 1.41 % 0.00 %

-0.02 (-0.69%)

USD 0.59B
QQQE Direxion NASDAQ-100 Equal.. 1.03 % 0.35 %

+0.12 (+-0.69%)

USD 1.25B
XEXP:CA iShares Exponential Techn.. 0.90 % 0.00 %

+0.09 (+-0.69%)

CAD 0.02B
WELE:XETRA Amundi S&P 500 Equal Weig.. 0.73 % 0.00 %

+0.01 (+-0.69%)

USD 0.78B
RSPE Invesco Exchange-Traded F.. 0.69 % 0.00 %

-0.27 (-0.69%)

USD 0.01B
XZEW:XETRA Xtrackers S&P 500 Equal W.. 0.51 % 0.00 %

-0.05 (-0.69%)

USD 0.59B
XEWE:XETRA Xtrackers S&P 500 Equal W.. 0.47 % 0.00 %

+0.02 (+-0.69%)

USD 0.57B
DFVE Doubleline Fortune 500 Eq.. 0.31 % 0.00 %

-0.03 (-0.69%)

USD 0.01B
XDED:XETRA Xtrackers S&P 500 Equal W.. 0.30 % 0.00 %

-0.07 (-0.69%)

USD 6.15B
XDEW:SW Xtrackers S&P 500 Equal W.. 0.30 % 0.00 %

+0.24 (+-0.69%)

USD 5.70B
ISPE:LSE iShares S&P 500 Equal Wei.. 0.29 % 0.00 %

+0.01 (+-0.69%)

USD 0.42B
SP2D:XETRA Invesco S&P 500 Equal Wei.. 0.28 % 0.00 %

-0.25 (-0.69%)

USD 0.21B
SP2Q:XETRA Invesco S&P 500 Equal Wei.. 0.28 % 0.00 %

-0.02 (-0.69%)

USD 0.28B
XEWG:LSE Xtrackers S&P 500 Equal W.. 0.27 % 0.00 %

+0.02 (+-0.69%)

USD 0.07B
XDEE:XETRA Xtrackers S&P 500 Equal W.. 0.27 % 0.00 %

+0.01 (+-0.69%)

USD 6.12B
EWSP:LSE iShares S&P 500 Equal Wei.. 0.27 % 0.00 %

N/A

USD 1.30B
SPED:LSE Invesco S&P 500 Equal Wei.. 0.26 % 0.00 %

+0.08 (+-0.69%)

USD 0.07B
SPEQ:LSE Invesco S&P 500 Equal Wei.. 0.26 % 0.00 %

+0.09 (+-0.69%)

USD 0.21B
EWSP:SW iShares S&P 500 Equal Wei.. 0.23 % 0.00 %

+0.01 (+-0.69%)

USD 1.30B
ARKG 0.00 % 0.75 %

N/A

N/A
BBH VanEck Biotech ETF 0.00 % 0.35 %

-0.25 (-0.69%)

USD 0.43B
BBP Virtus LifeSci Biotech Pr.. 0.00 % 0.79 %

+0.37 (+-0.69%)

USD 0.02B
BIB ProShares Ultra Nasdaq Bi.. 0.00 % 0.95 %

+0.10 (+-0.69%)

USD 0.09B
ETHO Etho Climate Leadership U.. 0.00 % 0.45 %

+0.03 (+-0.69%)

USD 0.18B
FLAG 0.00 % 1.52 %

N/A

N/A
IBB iShares Biotechnology ETF 0.00 % 0.47 %

-0.01 (-0.69%)

USD 7.43B
LABU Direxion Daily S&P Biotec.. 0.00 % 1.14 %

+2.29 (+-0.69%)

USD 1.01B
MUS:CA Mackenzie Maximum Diversi.. 0.00 % 0.58 %

+0.03 (+-0.69%)

CAD 0.10B
QQEW First Trust NASDAQ-100 Eq.. 0.00 % 0.60 %

+0.05 (+-0.69%)

USD 2.07B
QQXT First Trust NASDAQ-100 Ex.. 0.00 % 0.60 %

-0.49 (-0.69%)

USD 0.13B
BTEC Principal Healthcare Inno.. 0.00 % 0.42 %

+0.24 (+-0.69%)

USD 0.02B
ZHU:CA BMO Equal Weight US Healt.. 0.00 % 0.00 %

+0.72 (+-0.69%)

CAD 0.05B
LS:CA Middlefield Healthcare & .. 0.00 % 2.21 %

N/A

CAD 0.16B
GNOM Global X Genomics & Biote.. 0.00 % 0.00 %

-0.03 (-0.69%)

USD 0.09B
HWF:CA 0.00 % 0.00 %

N/A

N/A
HTEC Robo Global® Healthcare .. 0.00 % 0.00 %

-0.04 (-0.69%)

USD 0.06B
BTEC:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

-0.02 (-0.69%)

USD 0.51B
BTEK:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

-0.02 (-0.69%)

USD 0.50B
BTEE:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

-0.03 (-0.69%)

USD 0.04B
RSP Invesco S&P 500® Equal W.. 0.00 % 0.20 %

+0.20 (+-0.69%)

USD 53.72B
RYH 0.00 % 0.40 %

N/A

N/A
VOT Vanguard Mid-Cap Growth I.. 0.00 % 0.07 %

+0.91 (+-0.69%)

USD 13.22B
XT iShares Exponential Techn.. 0.00 % 0.47 %

+0.34 (+-0.69%)

USD 3.40B
XDEW:LSE Xtrackers S&P 500 Equal W.. 0.00 % 0.00 %

+0.07 (+-0.69%)

USD 5.64B
XDWE:LSE Xtrackers (IE) Public Lim.. 0.00 % 0.00 %

-5.00 (-0.69%)

USD 5.64B
2B70:F iShares NASDAQ US Biotech.. 0.00 % 0.00 %

N/A

USD 0.52B
XDEW:F Xtrackers (IE) Public Lim.. 0.00 % 0.00 %

+0.01 (+-0.69%)

USD 5.67B
2B70:XETRA iShares Nasdaq US Biotech.. 0.00 % 0.00 %

-0.04 (-0.69%)

USD 0.52B
XDEW:XETRA Xtrackers S&P 500 Equal W.. 0.00 % 0.00 %

-0.08 (-0.69%)

USD 2.73B
QBTL:CA AGFiQ US Market Neutral A.. 0.00 % 0.00 %

-0.08 (-0.69%)

CAD 0.26B
ZGEN:CA 0.00 % 0.00 %

N/A

N/A
XMLH:XETRA L&G Healthcare Breakthrou.. 0.00 % 0.00 %

-0.04 (-0.69%)

USD 0.07B
GERM ETFMG Treatments Testing .. 0.00 % 0.00 %

-0.33 (-0.69%)

USD 0.01B
FBT:LSE First Trust Global Funds .. 0.00 % 0.00 %

-3.10 (-0.69%)

USD 5.59M
FBTU:LSE First Trust Global Funds .. 0.00 % 0.00 %

+0.01 (+-0.69%)

USD 5.59M
IMCV iShares Morningstar Mid-C.. 0.00 % 0.00 %

-0.03 (-0.69%)

USD 0.59B
IBBQ Invesco Nasdaq Biotechnol.. 0.00 % 0.00 %

-0.02 (-0.69%)

USD 0.03B
MRNS:LSE Leverage Shares -3x Short.. -299.96 % 0.00 %

N/A

USD 0.09M

Market Performance

  Market Performance vs. Industry/Classification (Biotechnology) Market Performance vs. Exchange (OTCQB - U.S. Registered)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 37.73% 83% B 89% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 37.73% 83% B 89% A-
Trailing 12 Months  
Capital Gain 13.78% 73% C 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.78% 73% C 70% C-
Trailing 5 Years  
Capital Gain 900.00% 97% N/A 98% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 900.00% 97% N/A 98% N/A
Average Annual (5 Year Horizon)  
Capital Gain 130.87% 93% A 96% N/A
Dividend Return 130.87% 93% A 96% N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 221.82% 12% F 7% C-
Risk Adjusted Return 59.00% 96% N/A 85% B
Market Capitalization 0.02B 100% F 98% N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative earnings

The company had negative total earnings in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector